| Maan Barhoum, MD | |
|
755 S Milwaukee Ave, Suite 186, Libertyville, IL 60048-2905 | |
| (847) 573-9455 | |
| (847) 573-9456 |
| Full Name | Maan Barhoum |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 36 Years |
| Location | 755 S Milwaukee Ave, Libertyville, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114993979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 036115914 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Condell Medical Center | Libertyville, IL | Hospital |
| Northwestern Lake Forest Hospital | Lake forest, IL | Hospital |
| Advocate Illinois Masonic Medical Center | Chicago, IL | Hospital |
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Advocate Good Shepherd Hospital | Barrington, IL | Hospital |
| Entity Name | Patient First Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548258072 PECOS PAC ID: 3274446596 Enrollment ID: O20031111000788 |
News Archive
Though it is one of the most frequently used health indicators as more and more of us age, frailty - the medical term for increased vulnerability to declines in health or a loss of independence - remains under-studied and under-utilized, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society and the National Institute on Aging, with support from the Alliance for Academic Internal Medicine and The John A. Hartford Foundation.
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.
A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have achieved a major milestone with the launch of two clinical trials testing an experimental therapy in which patients' own immune cells are genetically engineered to fight their cancer.
› Verified 5 days ago
| Entity Name | Advanced Diabetes & Endocrince Center, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063500387 PECOS PAC ID: 2466458427 Enrollment ID: O20061013000479 |
News Archive
Though it is one of the most frequently used health indicators as more and more of us age, frailty - the medical term for increased vulnerability to declines in health or a loss of independence - remains under-studied and under-utilized, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society and the National Institute on Aging, with support from the Alliance for Academic Internal Medicine and The John A. Hartford Foundation.
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.
A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have achieved a major milestone with the launch of two clinical trials testing an experimental therapy in which patients' own immune cells are genetically engineered to fight their cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maan Barhoum, MD 755 S Milwaukee Ave, Suite 186, Libertyville, IL 60048-2905 Ph: (847) 573-9455 | Maan Barhoum, MD 755 S Milwaukee Ave, Suite 186, Libertyville, IL 60048-2905 Ph: (847) 573-9455 |
News Archive
Though it is one of the most frequently used health indicators as more and more of us age, frailty - the medical term for increased vulnerability to declines in health or a loss of independence - remains under-studied and under-utilized, so say researchers reporting on a prestigious conference hosted by the American Geriatrics Society and the National Institute on Aging, with support from the Alliance for Academic Internal Medicine and The John A. Hartford Foundation.
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.
A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have achieved a major milestone with the launch of two clinical trials testing an experimental therapy in which patients' own immune cells are genetically engineered to fight their cancer.
› Verified 5 days ago
Dr. George R Hvostik, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1860 W Winchester Rd Ste 107b, Libertyville, IL 60048 Phone: 847-996-0836 Fax: 847-996-6278 | |
Kalpana Puppala Bicknell, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 801 S. Milwaukee Ave., Advocate Condell Medical Center, Libertyville, IL 60048 Phone: 847-990-5260 Fax: 847-362-8031 | |
Dr. Rani Sharma, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 131 E Park Ave, Suite # 103, Libertyville, IL 60048 Phone: 847-968-2800 Fax: 847-968-2801 | |
Dr. Ahmad Mohamed Hassan, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 825 S Milwaukee Ave, Libertyville, IL 60048 Phone: 847-573-2845 | |
Kenneth R Margules, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 755 S Milwaukee Ave, Suite 250, Libertyville, IL 60048 Phone: 847-367-0072 Fax: 847-367-0876 | |
Dr. Robert B Johnson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 755 S. Milwaukee Avenue, Suite 263, Libertyville, IL 60048 Phone: 847-918-1500 Fax: 847-918-1500 |